SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-16-014324
Filing Date
2016-07-26
Accepted
2016-07-26 15:37:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7213092_13d-a.htm SC 13D/A 148117
  Complete submission text file 0000919574-16-014324.txt   149596
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
SYNTA PHARMACEUTICALS CORP (Subject) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82674 | Film No.: 161784314
SIC: 2834 Pharmaceutical Preparations

Mailing Address 731 ALEXANDER ROAD BUILDING 2 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

IRS No.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A